Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. Seymour (Oxford, United Kingdom), I. Psallidas (Oxford, United Kingdom), M. Dobson (Oxford, United Kingdom), N. Rahman (Oxford, United Kingdom). The patient perspective of treatment for Malignant Pleural Effusion (MPE)- results of a pilot service-evaluation questionnaire.. 2882

Member's Comments

No comment yet.

Related content which might interest you: Management of recurrent Malignant Pleural Effusion: what is the best method? Source: School Course 2014 - Thoracoscopy and Pleural Techniques Year: 2014 Management of recurrent Malignant Pleural Effusion: what is the best method? Source: ERS Course 2015 Year: 2015 Diagnostic yield of combined epidemiological and radiological data in Malignant Pleural Mesothelioma: A Pilot Study Source: International Congress 2019 – Indoor and outdoor air quality considerations Year: 2019 Malignant pleural mesothelioma: A retrospective analysis of 32 cases Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Does the sonographic presence and severity of pleural fluid septation have an impact on clinical outcomes in pleural infection? - Data from the Pleural Infection Longitudinal Outcome Study (PILOT) Source: International Congress 2018 – New methods for diagnosing and treating lung diseases Year: 2018 The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion Source: Eur Respir J, 55 (5) 1900980; 10.1183/13993003.00980-2019 Year: 2020 Survival of patients with malignant pleural effusions: a three-year prospective self-experience study Source: International Congress 2018 – Clinical management of pleural malignancies, including mesothelioma Year: 2018 Heterogeneous delivery of definitive interventions in malignant pleural effusions – results from a Danish survey. Source: International Congress 2019 – Pleural disease: applying the evidence Year: 2019 Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment Source: Eur Respir Rev 2016; 25: 472-486 Year: 2016 The role of a pleural service in optimising pleural disease management Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Late Breaking Abstract - Prognostic and therapeutic markers of malignant pleural effusion – The PROMISE study Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside Year: 2017 Role of Biomarkers for Predicting suspecting Malignant Mesothelioma in patients with Pleural Effusion presenting to a tertiary care hospital Source: International Congress 2019 – Pleural disease: applying the evidence Year: 2019 Pleural mesothelioma: Our experience in 132 cases Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Real life diagnosis in pleural effusion: a retrospective survey Source: Eur Respir J 2006; 28: Suppl. 50, 580s Year: 2006 The effect of co-cancer morbidity on mortality in subjects with malignant mesothelioma - a register based study Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Malignant pleural effusion - diagnosis and treatment Source: Eur Respir J 2002; 20: Suppl. 38, 272s Year: 2002 Tunneled indwelling pleural catheter (TPC) in recurrent malignant pleural effusions: A retrospective study of 230 patients Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Malignant pleural effusion management: is combining pleurodesis techniques the way forward? Results of the IPC-PLUS trial. Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs Year: 2017